ArticleMultidisciplinary respiratory medicine2026
Recupera e Respira: A sustainable pilot model for disposal of inhalers.
Article in Multidisciplinary respiratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recupera e Respira, a pilot project launched in the Friuli Venezia Giulia region in Italy in 2022, addresses the environmental impact of improper disposal of respiratory inhalers. When these medical devices are disposed of as regular household waste without segregation, they contribute to pollution with aluminum and plastic, and emission of residual hydrofluoroalkane (HFA). In collaboration with Federfarma, the national association representing over 19,000 private pharmacies affiliated with Italy's National Health Service, and with the support of Assinde, a company specializing in pharmaceutical returns management and the safe disposal of expired or unused medicines, Chiesi Italy suggested and implemented an institutionally approved collection and disposal system for empty inhalers. This initiative achieved a recovery rate of 24.6% over 3 years (calculated from IQVIA sell-out data referring to the Friuli Venezia Giulia region for September 2022 to June 2025), collecting over 111,000 inhalers from regional pharmacies. Proper disposal occurred at certified facilities capable of neutralizing hazardous components at high temperatures. The project highlights the role of pharmacies in educating patients and facilitating sustainable healthcare practices. An increase in recovery rates from 22.6% to 27.3% was observed in the first 2 years of project, with a sightly decrease over the third year. Overall, this study demonstrates the model's potential scalability, aligning with Chiesi's net zero goals by 2035. The study highlights how innovative waste management systems can effectively reduce the environmental burden of inhalers and foster public engagement in sustainability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.